Loading…

Ormond's disease - the current state of knowledge about diagnosis and treatment

Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, re...

Full description

Saved in:
Bibliographic Details
Published in:Journal of education, health and sport health and sport, 2022-09, Vol.12 (9), p.599-606
Main Authors: Dankiewicz, Sara, Bróż, Sebastian, Żelazny, Przemysław, Filipczak, Joanna, Swora, Aleksandra, Borowik, Joanna, Sygacz, Oliwer, Brodowski, Wojciech, Pawłowski, Piotr, Basta-Arciszewska, Katarzyna
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 606
container_issue 9
container_start_page 599
container_title Journal of education, health and sport
container_volume 12
creator Dankiewicz, Sara
Bróż, Sebastian
Żelazny, Przemysław
Filipczak, Joanna
Swora, Aleksandra
Borowik, Joanna
Sygacz, Oliwer
Brodowski, Wojciech
Pawłowski, Piotr
Basta-Arciszewska, Katarzyna
description Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited. The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease. State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential. Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.
doi_str_mv 10.12775/JEHS.2022.12.09.071
format article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</doaj_id><sourcerecordid>oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoMoWGr_gYfcPO2aZDebzVFKtZXCHtRzyMekbm03kqSI_95tK-Jp5h1mHpgHoVtKSsqE4PfPi-VLyQhjYy6JLImgF2jCKkmLtiLN5b_-Gs1S2hJCaMMp5WSCui7uw-DuEnZ9Ap0AFzi_A7aHGGHIOGWdAQePP4bwtQO3AaxNOORxXW-GkPqE9eBwjqDzfjy4QVde7xLMfusUvT0uXufLYt09reYP68JSLmghiGFO14Z708iKSqCOOetqycePOG9829a0bXjrjaVSaqeFrT0zrZXcCcurKVqduS7orfqM_V7HbxV0r06DEDdKx9zbHSjmjLAgJfNe1I46U0vRcNYQVwFYDSOrPrNsDClF8H88StTJsTo6VkfHY1ZEqtFx9QN7dW-0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><source>Open Access: DOAJ - Directory of Open Access Journals</source><creator>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</creator><creatorcontrib>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</creatorcontrib><description>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited. The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease. State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential. Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</description><identifier>ISSN: 2391-8306</identifier><identifier>EISSN: 2391-8306</identifier><identifier>DOI: 10.12775/JEHS.2022.12.09.071</identifier><language>eng</language><publisher>Kazimierz Wielki University</publisher><subject>glucocorticosteroid therapy ; IgG4-related disease ; immunosuppressive treatment ; Ormond's disease ; retroperitoneal fibrosis</subject><ispartof>Journal of education, health and sport, 2022-09, Vol.12 (9), p.599-606</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0756-387X ; 0000-0002-6171-0386 ; 0000-0002-3512-8368 ; 0000-0002-7759-1588 ; 0000-0003-3245-945X ; 0000-0001-6794-9112 ; 0000-0002-6191-2535 ; 0000-0002-9208-8462 ; 0000-0001-8369-6207 ; 0000-0002-1197-7218</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2102,27924,27925</link.rule.ids></links><search><creatorcontrib>Dankiewicz, Sara</creatorcontrib><creatorcontrib>Bróż, Sebastian</creatorcontrib><creatorcontrib>Żelazny, Przemysław</creatorcontrib><creatorcontrib>Filipczak, Joanna</creatorcontrib><creatorcontrib>Swora, Aleksandra</creatorcontrib><creatorcontrib>Borowik, Joanna</creatorcontrib><creatorcontrib>Sygacz, Oliwer</creatorcontrib><creatorcontrib>Brodowski, Wojciech</creatorcontrib><creatorcontrib>Pawłowski, Piotr</creatorcontrib><creatorcontrib>Basta-Arciszewska, Katarzyna</creatorcontrib><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><title>Journal of education, health and sport</title><description>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited. The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease. State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential. Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</description><subject>glucocorticosteroid therapy</subject><subject>IgG4-related disease</subject><subject>immunosuppressive treatment</subject><subject>Ormond's disease</subject><subject>retroperitoneal fibrosis</subject><issn>2391-8306</issn><issn>2391-8306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkE1LAzEQhoMoWGr_gYfcPO2aZDebzVFKtZXCHtRzyMekbm03kqSI_95tK-Jp5h1mHpgHoVtKSsqE4PfPi-VLyQhjYy6JLImgF2jCKkmLtiLN5b_-Gs1S2hJCaMMp5WSCui7uw-DuEnZ9Ap0AFzi_A7aHGGHIOGWdAQePP4bwtQO3AaxNOORxXW-GkPqE9eBwjqDzfjy4QVde7xLMfusUvT0uXufLYt09reYP68JSLmghiGFO14Z708iKSqCOOetqycePOG9829a0bXjrjaVSaqeFrT0zrZXcCcurKVqduS7orfqM_V7HbxV0r06DEDdKx9zbHSjmjLAgJfNe1I46U0vRcNYQVwFYDSOrPrNsDClF8H88StTJsTo6VkfHY1ZEqtFx9QN7dW-0</recordid><startdate>20220908</startdate><enddate>20220908</enddate><creator>Dankiewicz, Sara</creator><creator>Bróż, Sebastian</creator><creator>Żelazny, Przemysław</creator><creator>Filipczak, Joanna</creator><creator>Swora, Aleksandra</creator><creator>Borowik, Joanna</creator><creator>Sygacz, Oliwer</creator><creator>Brodowski, Wojciech</creator><creator>Pawłowski, Piotr</creator><creator>Basta-Arciszewska, Katarzyna</creator><general>Kazimierz Wielki University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0756-387X</orcidid><orcidid>https://orcid.org/0000-0002-6171-0386</orcidid><orcidid>https://orcid.org/0000-0002-3512-8368</orcidid><orcidid>https://orcid.org/0000-0002-7759-1588</orcidid><orcidid>https://orcid.org/0000-0003-3245-945X</orcidid><orcidid>https://orcid.org/0000-0001-6794-9112</orcidid><orcidid>https://orcid.org/0000-0002-6191-2535</orcidid><orcidid>https://orcid.org/0000-0002-9208-8462</orcidid><orcidid>https://orcid.org/0000-0001-8369-6207</orcidid><orcidid>https://orcid.org/0000-0002-1197-7218</orcidid></search><sort><creationdate>20220908</creationdate><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><author>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>glucocorticosteroid therapy</topic><topic>IgG4-related disease</topic><topic>immunosuppressive treatment</topic><topic>Ormond's disease</topic><topic>retroperitoneal fibrosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dankiewicz, Sara</creatorcontrib><creatorcontrib>Bróż, Sebastian</creatorcontrib><creatorcontrib>Żelazny, Przemysław</creatorcontrib><creatorcontrib>Filipczak, Joanna</creatorcontrib><creatorcontrib>Swora, Aleksandra</creatorcontrib><creatorcontrib>Borowik, Joanna</creatorcontrib><creatorcontrib>Sygacz, Oliwer</creatorcontrib><creatorcontrib>Brodowski, Wojciech</creatorcontrib><creatorcontrib>Pawłowski, Piotr</creatorcontrib><creatorcontrib>Basta-Arciszewska, Katarzyna</creatorcontrib><collection>CrossRef</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Journal of education, health and sport</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dankiewicz, Sara</au><au>Bróż, Sebastian</au><au>Żelazny, Przemysław</au><au>Filipczak, Joanna</au><au>Swora, Aleksandra</au><au>Borowik, Joanna</au><au>Sygacz, Oliwer</au><au>Brodowski, Wojciech</au><au>Pawłowski, Piotr</au><au>Basta-Arciszewska, Katarzyna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ormond's disease - the current state of knowledge about diagnosis and treatment</atitle><jtitle>Journal of education, health and sport</jtitle><date>2022-09-08</date><risdate>2022</risdate><volume>12</volume><issue>9</issue><spage>599</spage><epage>606</epage><pages>599-606</pages><issn>2391-8306</issn><eissn>2391-8306</eissn><abstract>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited. The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease. State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential. Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</abstract><pub>Kazimierz Wielki University</pub><doi>10.12775/JEHS.2022.12.09.071</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0756-387X</orcidid><orcidid>https://orcid.org/0000-0002-6171-0386</orcidid><orcidid>https://orcid.org/0000-0002-3512-8368</orcidid><orcidid>https://orcid.org/0000-0002-7759-1588</orcidid><orcidid>https://orcid.org/0000-0003-3245-945X</orcidid><orcidid>https://orcid.org/0000-0001-6794-9112</orcidid><orcidid>https://orcid.org/0000-0002-6191-2535</orcidid><orcidid>https://orcid.org/0000-0002-9208-8462</orcidid><orcidid>https://orcid.org/0000-0001-8369-6207</orcidid><orcidid>https://orcid.org/0000-0002-1197-7218</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2391-8306
ispartof Journal of education, health and sport, 2022-09, Vol.12 (9), p.599-606
issn 2391-8306
2391-8306
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae
source Open Access: DOAJ - Directory of Open Access Journals
subjects glucocorticosteroid therapy
IgG4-related disease
immunosuppressive treatment
Ormond's disease
retroperitoneal fibrosis
title Ormond's disease - the current state of knowledge about diagnosis and treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ormond's%20disease%20-%20the%20current%20state%20of%20knowledge%20about%20diagnosis%20and%20treatment&rft.jtitle=Journal%20of%20education,%20health%20and%20sport&rft.au=Dankiewicz,%20Sara&rft.date=2022-09-08&rft.volume=12&rft.issue=9&rft.spage=599&rft.epage=606&rft.pages=599-606&rft.issn=2391-8306&rft.eissn=2391-8306&rft_id=info:doi/10.12775/JEHS.2022.12.09.071&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true